Depreciation of Stoke Therapeutics, Inc. from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Stoke Therapeutics, Inc. annual and quarterly Depreciation in USD history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • Stoke Therapeutics, Inc. Depreciation for the quarter ending 31 Mar 2025 was $477,000, a 15% decline year-over-year.
  • Stoke Therapeutics, Inc. annual Depreciation for 2025 was $1,770,000, a 19% decline from 2024.
  • Stoke Therapeutics, Inc. annual Depreciation for 2024 was $2,177,000, a 12% decline from 2023.
  • Stoke Therapeutics, Inc. annual Depreciation for 2023 was $2,469,000, a 60% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

Stoke Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $1,770,000 -$407,000 -19% 01 Jan 2025 31 Dec 2025 10-K 16 Mar 2026 2025 FY
2024 $2,177,000 -$292,000 -12% 01 Jan 2024 31 Dec 2024 10-K 16 Mar 2026 2025 FY
2023 $2,469,000 +$923,000 +60% 01 Jan 2023 31 Dec 2023 10-K 18 Mar 2025 2024 FY
2022 $1,546,000 +$572,000 +59% 01 Jan 2022 31 Dec 2022 10-K 25 Mar 2024 2023 FY
2021 $974,000 +$86,000 +9.7% 01 Jan 2021 31 Dec 2021 10-K 06 Mar 2023 2022 FY
2020 $888,000 +$438,000 +97% 01 Jan 2020 31 Dec 2020 10-K 10 Mar 2022 2021 FY
2019 $450,000 +$236,000 +110% 01 Jan 2019 31 Dec 2019 10-K 09 Mar 2021 2020 FY
2018 $214,000 01 Jan 2018 31 Dec 2018 10-K 23 Mar 2020 2019 FY

Stoke Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $477,000 -$86,000 -15% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q1 2024 $563,000 -$34,000 -5.7% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q1 2023 $597,000 +$350,000 +142% 01 Jan 2023 31 Mar 2023 10-Q 06 May 2024 2024 Q1
Q1 2022 $247,000 +$11,000 +4.7% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $236,000 +$43,000 +22% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q1 2020 $193,000 +$113,000 +141% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q1 2019 $80,000 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.